Reverse‐phase chiral high‐performance liquid chromatography for separation of a diastereomer in alalevonadifloxacin: A novel antibacterial agent-Reference-Cited by-同舟云学术

Reverse‐phase chiral high‐performance liquid chromatography for separation of a diastereomer in alalevonadifloxacin: A novel antibacterial agent

Published:2021-02-07 Issue:6 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Ahirrao Vinod¹^ORCID,Rane Vipul¹,Patil Kiran¹^ORCID,More Kiran¹,Jadhav Rajiv¹^ORCID,Yeole Ravindra¹^ORCID

Affiliation:

1. Wockhardt Research Centre, D‐4, MIDC Aurangabad India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5079

Reference15 articles.

1. Chiral separation and thermodynamic investigation of WCK 3023: A novel oxazolidinone antibacterial agent, application to pre‐clinical pharmacokinetic study

2. Development and Validation of the Chiral Liquid Chromatography Method for Separation of Enantiomeric Impurity in Novel Oxazolidinone Antibacterial Agent WCK 4086

3. Chugh R. LakdavalaF. &Bhatia A. (2016).Safety and pharmacokinetics of multiple ascending doses of WCK 771 and WCK 2349. 26th European Congress on Clinical Microbiology and Infectious Disease Amsterdam. European Society of Clinical Microbiology and Infectious Diseases Basel Abstract P1268

4. ICH. (2005a).ICH topic Q6a specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.https://www.ich.org

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon footprint of the analytical laboratory and the three-dimensional approach to its reduction;Green Analytical Chemistry;2023-03

2. Synthesis, structural characterization of optical isomers and potential impurities in Alalevonadifloxacin mesylate;Synthetic Communications;2023-01-03

3. Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection;Bioorganic & Medicinal Chemistry Letters;2021-12

4. Diasterieomeric Separation of a Novel Chalcone Derivative by Chiral HPLC;Adıyaman University Journal of Science;2021-05-31

5. Reverse‐phase chiral high‐performance liquid chromatography for separation of a diastereomer in alalevonadifloxacin: A novel antibacterial agent;Biomedical Chromatography;2021-02-07